#sequenom

Will the FDA regulate Sequenom (and other cfDNA labs)?

Your author’s shoe circled

Sequenom launched its MaterniT21 cell free DNA screen on the marketplace in October 2011. Four years later, screens like Sequenom’s remain largely unregulated. The FDA is moving to change that. (more…)

Sequenom’s Whole Genome Sequencing: Reckless Prenatal Care

Sequenom, the maker of MaterniT21, has announced a further expansion of its testing: MaterniT Genome. This continues the reckless practice of prenatal genetic testing.  (more…)

On Friday, June 12, 2015, the Federal Circuit issued its decision in Ariosa Diagnostics, Inc. v. Sequenom, Inc. (Fed. Cir. 2015) finding that the claims of U.S. Patent No. 6,258,540 (the ‘540 patent) did not meet the patent-eligibility requirements of 35 U.S.C. §101. The ‘540 patent The ‘540 patent claims certain methods of using cell-free fetal DNA (cffDNA). In 1996, the inventors, Doctors…

1-in-5 pregnant women have NIPT

And Sequenom posted its first net profit last quarter.  (more…)

How many women have prenatal testing for Down syndrome?

Sequenom’s MaterniT21, et al., booth

A recent study calculated how many women in the United States have prenatal screening for Down syndrome. It’s a growing number.  (more…)